Tumor Metastasis:Special Issue of Science
LI Yang-si;WU Yi-long;Cancer Center;Guangdong General Hospital;Guangdong Academy of Medical Sciences;Guangdong Lung Cancer Institute;

..............page:129-131

xun zheng yi xue za zhi zheng gao zheng ding tong zhi

..............page:131

CheckMate 032 Trial:Opportunities and Challenges of Immunotherapy for Small Cell Lung Cancer
LEI Yuan-yuan;WU Si-pei;DONG Zhong-yi;Cancer Center;Guangdong General Hospital;Guangdong Academy of Medical Sciences;Guangdong Lung Cancer Institute;

..............page:132-133

Adjuvant Therapy in Early-Stage Small Cell Lung Cancer:How to Choose Wisely?
ZHANG Yi-chen;ZHONG Wen-zhao;Cancer Center;Guangdong General Hospital;Guangdong Academy of Medical Sciences;Guangdong Lung Cancer Institute;

..............page:134

Mechanisms of Acquired Drug Resistance to Anti-PD-1 Therapy: A New Immune Checkpoint TIM3 Activation
DONG Zhong-yi;ZHONG Wen-zhao;Cancer Center;Guangdong General Hospital;Guangdong Academy of Medical Sciences;Guangdong Lung Cancer Institute;

..............page:135+142

Go Beyond The Cognition of The Past:2016 Breast Cancer Endocrine Accurate Treatment
LIAO Ning;Department of Breast Surgery;Cancer Center;Guangdong General Hospital;Guangdong Academy of Medical Sciences;

..............page:136-142

Analysis of ESR1 Mutation in Circulating Tumor DNA Demonstrates Evolution during Therapy for Advanced Breast Cancer
YE Chang-sheng;YAO Guang-yu;ZHOU Wen-qi;Department of Breast Surgery;Nanfang Hospital;Southern Medical University;

..............page:143-144+148

The Interpretation of BOLERO-2 Trial: Clinical Application Analysis on Everolimus Plus Exemestane for Hormone Receptor-Positive Advanced Breast Cancer
WANG Xian-ming;XIAO Yu;Department of Thyroid and Breast Surgery;The First Affiliated Hospital of Shenzhen University;

..............page:145-148

PIK3CA Status in Circulating Tumor DNA Predicts Efficacy of Buparlisib(BUP) Plus Fulvestrant(FULV)in Breast Cancer Patient with Aromatase Inhibitors
WANG Ning-xia;ZHANG Yi-fang;The First Affiliated Hospital of Ji’nan University;

..............page:149-151

PALOMA-3 Trial:Fulvestrant Plus Palbociclib Improve Progression-Free Survival of Advanced Breast Cancer Patients with Endocrine Treatment Failure
WANG Shu-sen;ZHANG Liu-lu;Department of Medical Oncology;Sun Yat-sen University Cancer Hospital;

..............page:152-154

xun zheng yi xue za zhi kai tong scholarone manuscripts zai xian tou shen gao xi tong de tong zhi

..............page:154

Relationship between Clinicians’ Professional Stressors and Coping Styles
ZHANG Bai-fang;YIN Shao-ya;ZHAO Jing-bo;Psychological Department;The First Affiliated Hospital of Guangdong Pharmaceutical University;Psychological Department;School of Public Health and Tropical Medicine;Southern Medical University;

..............page:155-158

A Method of Data Extraction and Meta-Analysis for miRNA-122 in The Diagnosis of Chronic Viral Hepatitis from Healthy
QU Zhen;HU Cui-ping;Guangdong Food and Drug Vocational College;School of Basic Medical Sciences;Wuhan University;School of Pharmaceutical Sciences;Wuhan University;

..............page:159-164

Effect of Intraoperative Restrictive Fluid Regimes on Outcome after Intraabdominal Surgery:A Meta-Analysis
DUAN Jun-cheng;JIA Lei;GE Yao;HU Bin;Department of Anesthesiology;Xizang Minzu University Affiliated Hospital;Department of Anesthesiology;Yan’an University Affiliated Hospital;

..............page:165-173

Oral Contraceptive May Increase The Risk of Breast Cancer among Chinese Women:A Meta-Analysis
SHI Bin-hao;XU Ping;SUN Ye-huan;The First Clinic Medical College;Anhui Medical University;Department of Epidemiology and Biostatistics;Anhui Medical University;Evidence-Based Medicine Center;Anhui Medical University;

..............page:174-179+185

Bibliometric Analysis and Quality Evaluation of Qualitative Research Published in Chinese Medical Association Journals
ZHAO Rui;BAI Zheng-gang;ZHANG Jing-yi;LENG Yun-xi;Evidence-Based Medicine Centre of Lanzhou University;

..............page:180-185

Crizotinib Neoadjuvant Therapy for ⅢA/N2 Lung Cancer
ZHONG Wen-zhao;CHEN Ying;Cancer Center;Guangdong General Hospital;Guangdong Academy of Medical Sciences;Guangdong Lung Cancer Institute;

..............page:186-192

xun zheng yi xue oa qi kan 2015 nian 1 yue 1 ri zheng shi shang xian

..............page:192

xun zheng yi xue gao yue

..............page:193